13 Followers on Owler
OverviewCompetitorsFundingNews & Insights

InflaRx Competitors or Alternatives

InflaRx's top competitors include Akari Therapeutics, ChemoCentryx and Alnylam.

Unlock 18 more competitors →

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

  • FUNDING

    REVENUE

  • EMPLOYEES

    FUNDING

  • REVENUE

  • CEO RATING

  • EMPLOYEES

  • FUNDING

  • REVENUE

InflaRx's company profile

Niels C. Riedemann

Founder & CEO

90/100
66
$444.9M
$ < 1M
  • $444.9M
    $ < 1M
  • 66
    $444.9M
  • $ < 1M
  • 90/100
  • 66
  • $444.9M
  • $ < 1M
View ProfileView
1
InflaRx's Competitor - Akari Therapeutics logo

Abizer Gaslightwala

President & CEO

83/100
9
$155.9M
$ < 1M
  • $155.9M
    $ < 1M
  • 9
    $155.9M
  • $ < 1M
  • 83/100
  • 9
  • $155.9M
  • $ < 1M
View ProfileView
2
InflaRx's Competitor - ChemoCentryx logo

Thomas J. Schall

President & CEO

84/100
100 - 250
$679.3M
$25M - 100M
  • $679.3M
    $25M - 100M
  • 100 - 250
    $679.3M
  • $25M - 100M
  • 84/100
  • 100 - 250
  • $679.3M
  • $25M - 100M
View ProfileView
3
InflaRx's Competitor - Alnylam logo

John Maraganore

CEO

88/100
2,000
$5.3B
$4.8B
  • $5.3B
    $4.8B
  • 2,000
    $5.3B
  • $4.8B
  • 88/100
  • 2,000
  • $5.3B
  • $4.8B
View ProfileView
4
InflaRx's Competitor - Kymab logo

CEO

- -
1,000 - 5,000
$229M
$100M - 500M
  • $229M
    $100M - 500M
  • 1,000 - 5,000
    $229M
  • $100M - 500M
  • - -
  • 1,000 - 5,000
  • $229M
  • $100M - 500M
View ProfileView
5
InflaRx's Competitor - XOMA Royalty logo

Owen Hughes

CEO

88/100
10
$42M
$48.6M
  • $42M
    $48.6M
  • 10
    $42M
  • $48.6M
  • 88/100
  • 10
  • $42M
  • $48.6M
View ProfileView
InflaRx's top 21 competitors are Akari Therapeutics, ChemoCentryx, Alnylam, XBiotech, Kymab, XOMA Royalty, Alder BioPharmaceuticals, Novartis, NovImmune, Regeneron, Crescendo Biologics, Amgen, Teva, Lilly, Apexigen, CEVEC, Jnana, Memo Therapeutics AG, Aclaris, Elcelyx Therapeutics and FairJourney Biologics. Together they have raised over 49.0B between their estimated 191.6K employees. InflaRx has 66 employees and is ranked 15th among it's top 10 competitors. The top 10 competitors average 8,709.

InflaRx VS Akari Therapeutics

Akari Therapeutics is the biggest rival of InflaRx. Akari Therapeutics was founded in 2004, and its headquarters is in Tampa, Florida. Akari Therapeutics operates in the Biotechnology industry. Akari Therapeutics has 57 fewer employees than InflaRx.

InflaRx VS ChemoCentryx

ChemoCentryx has been one of InflaRx's top competitors. ChemoCentryx is a Private company that was founded in San Carlos, California in 1997. ChemoCentryx is in the Pharmaceuticals industry. ChemoCentryx has 112 more employees vs. InflaRx.

InflaRx VS Alnylam

Alnylam is InflaRx's #3 rival. Alnylam was founded in 2002 in Cambridge, Massachusetts. Alnylam is in the Biotechnology field. Alnylam generates $4.8B more revenue than InflaRx.

Looking for similar companies to InflaRx?

Similar Companies

Pharmaceuticals & Biotechnology companies in Jena

See 17 companies 
Companies in Jena with employees in 25-100 range

See 34 companies 
Pharmaceuticals & Biotechnology companies in Thuringia

See 21 companies 
Companies in Thuringia with employees in 25-100 range

See 93 companies 
Pharmaceuticals companies in Germany

See 1,759 companies 
Pharmaceuticals & Biotechnology companies in Germany

See 2,600 companies 
Pharmaceuticals companies with employees in 25-100 range

See 2,851 companies 
Pharmaceuticals & Biotechnology companies with employees in 25-100 range

See 7,091 companies 
Pharmaceuticals companies in Europe

See 8,213 companies 

Advanced Search

PRO

Discover new companies using five search parameters, including sector, location, public/private company status, employee count, and annual revenue.

Discover new companies using five search parameters.

Trending News for InflaRx and InflaRx's Competitors

August 12, 2026Citybizlist
Amplifica Holdings Group has closed an oversubscribed $26 million Series B financing to advance clinical development of its injectable therapies... Rea...
August 12, 2026Kashmir Newsline
Hyderabad (Telangana) [India], August 12: Amgen (NASDAQ: AMGN) today announced plans to open a new Science and Innovation Center at Genome Valley in Hy...
Today 3:00 AMPR-Inside
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / August 12, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Rege...

Frequently Asked Questions about InflaRx

  1. Who are InflaRx's top competitors?

    InflaRx's top 3 competitors are Akari Therapeutics, ChemoCentryx, Alnylam.

  2. Who is similar to InflaRx?

    Akari Therapeutics is the most similar to InflaRx. ChemoCentryx and Alnylam are also similar to InflaRx.

  1. Are InflaRx and Akari Therapeutics competitors?

    Yes, Akari Therapeutics is one of InflaRx’s top competitors.